Since CD99 antigen is also expressed in synovial sarcoma and low-grade fibromyxoid sarcoma, patients were included in the study only after the clinical confirmation of Ewing sarcoma diagnosis, as described in method section. The gene discussed is CD99; the disease is synovial sarcoma.